Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001053133 | SCV001217379 | likely benign | Saldino-Mainzer syndrome | 2024-12-02 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002481974 | SCV002797122 | uncertain significance | Saldino-Mainzer syndrome; Retinitis pigmentosa 80 | 2022-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002553308 | SCV003752068 | uncertain significance | Inborn genetic diseases | 2022-12-21 | criteria provided, single submitter | clinical testing | The c.3173T>C (p.L1058S) alteration is located in exon 25 (coding exon 23) of the IFT140 gene. This alteration results from a T to C substitution at nucleotide position 3173, causing the leucine (L) at amino acid position 1058 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |